ECSP17012504A - Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camarones - Google Patents
Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camaronesInfo
- Publication number
- ECSP17012504A ECSP17012504A ECIEPI201712504A ECPI201712504A ECSP17012504A EC SP17012504 A ECSP17012504 A EC SP17012504A EC IEPI201712504 A ECIEPI201712504 A EC IEPI201712504A EC PI201712504 A ECPI201712504 A EC PI201712504A EC SP17012504 A ECSP17012504 A EC SP17012504A
- Authority
- EC
- Ecuador
- Prior art keywords
- clay
- product
- effects
- shrimp
- clostridium
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 241000143060 Americamysis bahia Species 0.000 title 1
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 239000004927 clay Substances 0.000 abstract 4
- 241000193468 Clostridium perfringens Species 0.000 abstract 2
- 241000193163 Clostridioides difficile Species 0.000 abstract 1
- 241000193403 Clostridium Species 0.000 abstract 1
- 241000238557 Decapoda Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 206010028851 Necrosis Diseases 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 241000607272 Vibrio parahaemolyticus Species 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 235000013330 chicken meat Nutrition 0.000 abstract 1
- 208000021735 chronic enteritis Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000017074 necrotic cell death Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Fodder In General (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Farming Of Fish And Shellfish (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Los Solicitantes han examinado dos especies de Clostridium, Clostridium difficile y Clostridium perfringens, y encontraron que las arcillas pueden adsorber la toxina producida por ambas y que un producto mezclado de arcilla puede disminuir los efectos de una afección prominente en pollos y conocida como Enteritis Crónica, que es causada por C. perfringens. Recientemente una arcilla o una mezcla de arcilla que puede ser una combinación de arcilla, levadura y una forma de un aminoácido funcional, se examinó y se encontró que ayuda a disminuir los efectos de la enfermedad de necrosis hepatopancreática aguda (AHPND) que también es conocida como Síndrome de Mortalidad Temprana (EMS) en camarones cuando se utilizó un modelo de estimulación que incluyó Vibrio parahaemolyticus.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462032238P | 2014-08-01 | 2014-08-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP17012504A true ECSP17012504A (es) | 2017-05-31 |
Family
ID=55218385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECIEPI201712504A ECSP17012504A (es) | 2014-08-01 | 2017-02-24 | Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camarones |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN107106597A (es) |
| EC (1) | ECSP17012504A (es) |
| MX (1) | MX2017001426A (es) |
| WO (1) | WO2016019343A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015007549B1 (pt) | 2012-10-02 | 2022-04-05 | Oil-Dri Corporation Of America | Produto de argila e seus usos |
| CN110099743B (zh) * | 2016-12-22 | 2022-06-14 | 弗门尼舍有限公司 | 具有矿物层的微胶囊 |
| CN111132676A (zh) * | 2017-09-19 | 2020-05-08 | 日本纽翱医药股份有限公司 | 含有5－氨基乙酰丙酸的十足目用组合物 |
| CN110547359B (zh) * | 2019-08-29 | 2022-07-26 | 清远海贝生物技术有限公司 | 一种虾用抗肠道弧菌保健料 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101321471B (zh) * | 2005-07-19 | 2016-08-17 | 米奥尼克斯公司 | 用于食品和饲料的防腐剂和添加剂 |
| WO2010028215A1 (en) * | 2008-09-05 | 2010-03-11 | Mionix Corporation | Antimicrobial fish and shrimp feed |
| BR112015007549B1 (pt) * | 2012-10-02 | 2022-04-05 | Oil-Dri Corporation Of America | Produto de argila e seus usos |
-
2015
- 2015-07-31 WO PCT/US2015/043302 patent/WO2016019343A1/en not_active Ceased
- 2015-07-31 CN CN201580048525.5A patent/CN107106597A/zh active Pending
- 2015-07-31 MX MX2017001426A patent/MX2017001426A/es unknown
-
2017
- 2017-02-24 EC ECIEPI201712504A patent/ECSP17012504A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016019343A1 (en) | 2016-02-04 |
| CN107106597A (zh) | 2017-08-29 |
| MX2017001426A (es) | 2017-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015022191A2 (pt) | compostos heteroarila, seu uso e composição que os compreende | |
| BR112019001607A2 (pt) | inibidores macrocíclicos de quinases | |
| CL2015003731A1 (es) | Inhibidores de bromodominios | |
| MX2016016871A (es) | Metodo para mejorar el valor nutricional de pienso para animales. | |
| BR112015021888A8 (pt) | inibidores de dna-pk, seus usos e composição farmacêutica | |
| ES2838803T3 (es) | Método para reducir la producción total de gas y/o la producción de metano en un animal rumiante | |
| CL2015003117A1 (es) | Modificaciones en la estructura cristalina | |
| BR112015020389A2 (pt) | compostos carbazol úteis como inibidores de bromodomínio | |
| CL2015002677A1 (es) | Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial. | |
| UA117032C2 (uk) | Селективний інгібітор фосфатидилінозитол-3-кінази-гамма | |
| MA37213A1 (fr) | Nouveaux derives phosphates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| IN2015DN03322A (es) | ||
| MX2022002946A (es) | Inhibidores de cdk y su uso como productos farmaceuticos. | |
| ECSP14026138A (es) | Uracilos sustituidos bicíclicamente y uso de los mismos | |
| UY35693A (es) | Pirazolo[1,5-a]piridin-3-carboxamidas sustituidas y su uso | |
| MX370900B (es) | Derivados del isocromeno como inhibidores de las fosfoinositido-3 cinasas. | |
| AR103077A1 (es) | Método para la producción de un sistema de administración farmacéutica | |
| EA201692313A1 (ru) | Производные индолизина в качестве ингибиторов фосфоинозитид-3-киназ | |
| CL2015002835A1 (es) | Nuevos derivados de piridina | |
| WO2014106825A3 (en) | Methods and devices for identifying improper medical reporting | |
| BR112017005660A2 (pt) | novos ativadores de guanilato ciclase solúvel e sua utilização | |
| ECSP17012504A (es) | Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camarones | |
| DOP2016000297A (es) | Composiciones farmacéuticas útiles para tratar enfermedades infecciosas | |
| PH12017501071B1 (en) | Dihydropyrimidin-2-one compounds and medical use thereof | |
| MX384303B (es) | Composiciones y métodos para metabolismo muscular mejorado. |